Stock Events

Sage Therapeutics (SAGE) Q1 2024 Earnings

SAGE -0.70%
10JunExpected
Q3 2023
Q4 2023
Q2 2024
Q1 2024
-3.37
-2.43
-1.49
-0.55

Details

Expected EPS
-1.65
Actual EPS
-1.8
Surprise EPS
-0.15
Surprise Percent
+9.09%

Description

Sage Therapeutics (SAGE) has reported earnings of -1.8 per share for Q1 2024.

0 Comments

Share your thoughts